Publications by authors named "Simon Cleall"

Claim this Profile
P
Population Pharmacokinetics of Vixotrigine in Healthy Volunteers and Subjects with Trigeminal Neuralgia, Painful Lumbosacral Radiculopathy and Erythromelalgia.
Himanshu Naik, Yuan Zhao, Fiona Forrestal, Simon Cleall, Howard Bockbrader

Eur J Drug Metab Pharmacokinet· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a premixed versus a basal-plus insulin regimen as intensification for type 2 diabetes by timing of the main meal.
Jorge L Gross, Arturo Rojas, Sanjiv Shah, Francisco J Tinahones, Simon Cleall

Curr Med Res Opin· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the «Conversation Map™» tools on understanding of diabetes by Spanish patients with type 2 diabetes mellitus: a randomized, comparative study.
Maite Penalba, Luis Moreno, Amelia Cobo, Jesús Reviriego, Angel Rodríguez, Simon Cleall

Endocrinol Nutr· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like peptide 1 receptor agonist or bolus insulin with optimized basal insulin in type 2 diabetes.
Michaela Diamant, Michael A Nauck, Rimma Shaginian, James K Malone, Simon Cleall

Diabetes Care· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: the SWING study.
Matthew Reaney, Katarzyna Cypryk, Nicholas Tentolouris, Michael Jecht, Simon Cleall

Diabetes Res Clin Pract· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis